← Leaderboards
William L. Carroll
University Of Utah
$23,653,738
Attributed
$26,560,764
Total exposure
40
Grants
35
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,579,626 · 41
By mechanism
P30$33,174,801 · 33
R01$7,806,891 · 3
T32$2,537,738 · 1
R21$739,763 · 2
U10$241,833 · 1
P50$78,600 · 1
Top collaborators
- David E. Levy5 shared
- Timothee Lionnet5 shared
- Aristotelis Tsirigos5 shared
- Julie L Locher2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Jonathan Eric Constance$2,718,439
Others in their field
Top investigators on “Cancer Center Support Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$253,882,416
- Mary L. Disis · University Of Washington$91,856,641
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$87,214,340
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$79,061,055
- Robert J Gray · Dana-Farber Cancer Institute$78,329,401
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
Research focus
Cancer Center Support GrantMalignant NeoplasmsResearch PersonnelProgramsInstructionLaboratoriesCollaborationsFundingMemberInstitutesBaseServicesResource SharingClinical ResearchResourcesPublicationsClinical TrialsTranslational ResearchAreaDesignTechnologyTrainingKaplan Cancer CenterMedical Center
Grant awards (187)
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome$430,442
R01 · FY2025 · CA · contact PI
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome$416,102
R01 · FY2024 · CA · contact PI
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome$436,432
R01 · FY2023 · CA · contact PI
Cancer Genome Dynamics (CGD) Research Program$32,775
P30 · FY2023 · CA · contact PI
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome$442,612
R01 · FY2022 · CA · contact PI
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome$475,941
R01 · FY2021 · CA · contact PI
Molecular, Oncology and Immunology Training Grant$591,264
T32 · FY2020 · CA
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)$417,172
R01 · FY2020 · CA · contact PI
Molecular, Oncology and Immunology Training Grant$582,505
T32 · FY2019 · CA
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)$447,228
R01 · FY2019 · CA · contact PI
Molecular, Oncology and Immunology Training Grant$552,383
T32 · FY2018 · CA
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)$461,060
R01 · FY2018 · CA · contact PI
Molecular, Oncology and Immunology Training Grant$555,426
T32 · FY2017 · CA
DEVELOPMENTAL FUNDS$465,566
P30 · FY2017 · CA · contact PI
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)$454,699
R01 · FY2017 · CA · contact PI
SENIOR LEADERSHIP$365,655
P30 · FY2017 · CA · contact PI
BIOSTATISTICS$220,932
P30 · FY2017 · CA · contact PI
BIOMEDICAL INFORMATICS$182,659
P30 · FY2017 · CA · contact PI
BIOREPOSITORY CENTER$159,320
P30 · FY2017 · CA · contact PI
CLINICAL TRIALS OFFICE$156,001
P30 · FY2017 · CA · contact PI
GENOME TECHNOLOGY CENTER$148,142
P30 · FY2017 · CA · contact PI
EXPOSURE FACILITY$91,508
P30 · FY2017 · CA · contact PI
ADMINISTRATION$83,217
P30 · FY2017 · CA · contact PI
VACCINE AND CELL THERAPY CORE LABORATORY$82,636
P30 · FY2017 · CA · contact PI
EXPERIMENTAL PATHOLOGY$81,476
P30 · FY2017 · CA · contact PI
TRANSLATIONAL RESEARCH CORE$81,475
P30 · FY2017 · CA · contact PI
RNAI$81,475
P30 · FY2017 · CA · contact PI
PROTEOMICS$69,836
P30 · FY2017 · CA · contact PI
FLOW CYTOMETRY AND CELL SORTING$64,423
P30 · FY2017 · CA · contact PI
PLANNING AND EVALUATION$51,793
P30 · FY2017 · CA · contact PI
DATA AND SAFETY MONITORING$33,085
P30 · FY2017 · CA · contact PI
BREAST CANCER$27,088
P30 · FY2017 · CA · contact PI
ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS$27,088
P30 · FY2017 · CA · contact PI
EPIDEMIOLOGY AND CANCER CONTROL$27,088
P30 · FY2017 · CA · contact PI
MELANOMA RESEARCH$27,088
P30 · FY2017 · CA · contact PI
GENITOURINARY CANCERS$27,088
P30 · FY2017 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$26,540
P30 · FY2017 · CA · contact PI
CANCER IMMUNOLOGY$22,567
P30 · FY2017 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH SUPPORT$18,841
P30 · FY2017 · CA · contact PI
GROWTH CONTROL$13,546
P30 · FY2017 · CA · contact PI
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)$472,074
R01 · FY2016 · CA · contact PI
DEVELOPMENTAL FUNDS$449,226
P30 · FY2016 · CA · contact PI
SENIOR LEADERSHIP$352,823
P30 · FY2016 · CA · contact PI
Molecular, Oncology and Immunology Training Grant$256,160
T32 · FY2016 · CA
BIOSTATISTICS$218,794
P30 · FY2016 · CA · contact PI
BIOMEDICAL INFORMATICS$176,246
P30 · FY2016 · CA · contact PI
BIOREPOSITORY CENTER$153,731
P30 · FY2016 · CA · contact PI
CLINICAL TRIALS OFFICE$150,524
P30 · FY2016 · CA · contact PI
GENOME TECHNOLOGY CENTER$142,942
P30 · FY2016 · CA · contact PI
EXPOSURE FACILITY$88,299
P30 · FY2016 · CA · contact PI
ADMINISTRATION$80,297
P30 · FY2016 · CA · contact PI
VACCINE AND CELL THERAPY CORE LABORATORY$79,735
P30 · FY2016 · CA · contact PI
EXPERIMENTAL PATHOLOGY$78,618
P30 · FY2016 · CA · contact PI
RNAI$78,616
P30 · FY2016 · CA · contact PI
TRANSLATIONAL RESEARCH CORE$78,614
P30 · FY2016 · CA · contact PI
PROTEOMICS$67,381
P30 · FY2016 · CA · contact PI
FLOW CYTOMETRY AND CELL SORTING$62,165
P30 · FY2016 · CA · contact PI
PLANNING AND EVALUATION$49,974
P30 · FY2016 · CA · contact PI
DATA AND SAFETY MONITORING$31,923
P30 · FY2016 · CA · contact PI
ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS$26,139
P30 · FY2016 · CA · contact PI
GENITOURINARY CANCERS$26,139
P30 · FY2016 · CA · contact PI
BREAST CANCER$26,139
P30 · FY2016 · CA · contact PI
EPIDEMIOLOGY AND CANCER CONTROL$26,139
P30 · FY2016 · CA · contact PI
MELANOMA RESEARCH$26,139
P30 · FY2016 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$25,606
P30 · FY2016 · CA · contact PI
CANCER IMMUNOLOGY$21,775
P30 · FY2016 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH SUPPORT$18,178
P30 · FY2016 · CA · contact PI
GROWTH CONTROL$13,073
P30 · FY2016 · CA · contact PI
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)$432,951
R01 · FY2015 · CA · contact PI
DEVELOPMENTAL FUNDS$430,340
P30 · FY2015 · CA · contact PI
SENIOR LEADERSHIP$337,988
P30 · FY2015 · CA · contact PI
BIOSTATISTICS$204,216
P30 · FY2015 · CA · contact PI
BIOMEDICAL INFORMATICS$168,838
P30 · FY2015 · CA · contact PI
BIOREPOSITORY CENTER$147,264
P30 · FY2015 · CA · contact PI
CLINICAL TRIALS OFFICE$144,198
P30 · FY2015 · CA · contact PI
GENOME TECHNOLOGY CENTER$136,932
P30 · FY2015 · CA · contact PI
EXPOSURE FACILITY$84,583
P30 · FY2015 · CA · contact PI
ADMINISTRATION$76,922
P30 · FY2015 · CA · contact PI
VACCINE AND CELL THERAPY CORE LABORATORY$76,384
P30 · FY2015 · CA · contact PI
RNAI$75,310
P30 · FY2015 · CA · contact PI
TRANSLATIONAL RESEARCH CORE$75,310
P30 · FY2015 · CA · contact PI
EXPERIMENTAL PATHOLOGY$75,310
P30 · FY2015 · CA · contact PI
PROTEOMICS$64,551
P30 · FY2015 · CA · contact PI
FLOW CYTOMETRY AND CELL SORTING$59,549
P30 · FY2015 · CA · contact PI
PLANNING AND EVALUATION$47,875
P30 · FY2015 · CA · contact PI
DATA AND SAFETY MONITORING$30,582
P30 · FY2015 · CA · contact PI
EPIDEMIOLOGY AND CANCER CONTROL$25,037
P30 · FY2015 · CA · contact PI
MELANOMA RESEARCH$25,037
P30 · FY2015 · CA · contact PI
ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS$25,037
P30 · FY2015 · CA · contact PI
GENITOURINARY CANCERS$25,037
P30 · FY2015 · CA · contact PI
BREAST CANCER$25,037
P30 · FY2015 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$24,533
P30 · FY2015 · CA · contact PI
CANCER IMMUNOLOGY$20,858
P30 · FY2015 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH SUPPORT$17,416
P30 · FY2015 · CA · contact PI
GROWTH CONTROL$12,520
P30 · FY2015 · CA · contact PI
DEVELOPMENTAL FUNDS$451,624
P30 · FY2014 · CA · contact PI
SENIOR LEADERSHIP$352,548
P30 · FY2014 · CA · contact PI
BIOSTATISTICS$209,033
P30 · FY2014 · CA · contact PI
BIOMEDICAL INFORMATICS$171,078
P30 · FY2014 · CA · contact PI
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)$150,443
R01 · FY2014 · CA · contact PI
BIOREPOSITORY CENTER$147,933
P30 · FY2014 · CA · contact PI
CLINICAL TRIALS OFFICE$144,643
P30 · FY2014 · CA · contact PI
GENOME TECHNOLOGY CENTER$136,849
P30 · FY2014 · CA · contact PI
EXPOSURE FACILITY$80,689
P30 · FY2014 · CA · contact PI
ADMINISTRATION$72,471
P30 · FY2014 · CA · contact PI
VACCINE AND CELL THERAPY CORE LABORATORY$71,892
P30 · FY2014 · CA · contact PI
EXPERIMENTAL PATHOLOGY$70,740
P30 · FY2014 · CA · contact PI
RNAI$70,740
P30 · FY2014 · CA · contact PI
TRANSLATIONAL RESEARCH CORE$70,739
P30 · FY2014 · CA · contact PI
PROTEOMICS$59,197
P30 · FY2014 · CA · contact PI
FLOW CYTOMETRY AND CELL SORTING$53,831
P30 · FY2014 · CA · contact PI
PLANNING AND EVALUATION$41,308
P30 · FY2014 · CA · contact PI
DATA AND SAFETY MONITORING$22,757
P30 · FY2014 · CA · contact PI
GENITOURINARY CANCERS$16,806
P30 · FY2014 · CA · contact PI
MELANOMA RESEARCH$16,806
P30 · FY2014 · CA · contact PI
BREAST CANCER$16,806
P30 · FY2014 · CA · contact PI
EPIDEMIOLOGY AND CANCER CONTROL$16,806
P30 · FY2014 · CA · contact PI
ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS$16,806
P30 · FY2014 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$16,264
P30 · FY2014 · CA · contact PI
CANCER IMMUNOLOGY$12,323
P30 · FY2014 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH SUPPORT$8,630
P30 · FY2014 · CA · contact PI
GROWTH CONTROL$3,377
P30 · FY2014 · CA · contact PI
Cancer Center Support Grant$2,278,153
P30 · FY2013 · CA · contact PI
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)$406,973
R01 · FY2013 · CA · contact PI
DEVELOPMENTAL FUNDS$401,459
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$315,307
P30 · FY2013 · CA · contact PI
BIOSTATISTICS$195,531
P30 · FY2013 · CA · contact PI
BIOMEDICAL INFORMATICS$157,507
P30 · FY2013 · CA · contact PI
Food and Eating Behaviors of Head and Neck Cancer Patients$149,760
R21 · FY2013 · CA
BIOREPOSITORY CENTER$137,380
P30 · FY2013 · CA · contact PI
CLINICAL TRIALS OFFICE$134,521
P30 · FY2013 · CA · contact PI
GENOME TECHNOLOGY CENTER$127,741
P30 · FY2013 · CA · contact PI
EXPOSURE FACILITY$78,906
P30 · FY2013 · CA · contact PI
ADMINISTRATION$71,761
P30 · FY2013 · CA · contact PI
VACCINE AND CELL THERAPY CORE LABORATORY$71,259
P30 · FY2013 · CA · contact PI
TRANSLATIONAL RESEARCH CORE$70,256
P30 · FY2013 · CA · contact PI
RNAI$70,256
P30 · FY2013 · CA · contact PI
EXPERIMENTAL PATHOLOGY$70,255
P30 · FY2013 · CA · contact PI
PROTEOMICS$60,218
P30 · FY2013 · CA · contact PI
FLOW CYTOMETRY AND CELL SORTING$55,552
P30 · FY2013 · CA · contact PI
PLANNING AND EVALUATION$44,663
P30 · FY2013 · CA · contact PI
ADMINISTRATION$31,251
P30 · FY2013 · CA · contact PI
Cancer Center Support Grant$31,251
P30 · FY2013 · CA · contact PI
DATA AND SAFETY MONITORING$28,531
P30 · FY2013 · CA · contact PI
GENITOURINARY CANCERS$23,356
P30 · FY2013 · CA · contact PI
EPIDEMIOLOGY AND CANCER CONTROL$23,356
P30 · FY2013 · CA · contact PI
BREAST CANCER$23,356
P30 · FY2013 · CA · contact PI
ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS$23,356
P30 · FY2013 · CA · contact PI
MELANOMA RESEARCH$23,356
P30 · FY2013 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$22,887
P30 · FY2013 · CA · contact PI
CANCER IMMUNOLOGY$19,456
P30 · FY2013 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH SUPPORT$16,248
P30 · FY2013 · CA · contact PI
GROWTH CONTROL$11,679
P30 · FY2013 · CA · contact PI
Cancer Center Support Grant$2,512,026
P30 · FY2012 · CA · contact PI
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)$432,951
R01 · FY2012 · CA · contact PI
Sr. Leadership$335,538
P30 · FY2012 · CA · contact PI
Food and Eating Behaviors of Head and Neck Cancer Patients$191,183
R21 · FY2012 · CA
Planning and Evaluation$59,112
P30 · FY2012 · CA · contact PI
Cancer Center Support Grant$2,512,026
P30 · FY2011 · CA · contact PI
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)$480,601
R01 · FY2011 · CA · contact PI
Sr. Leadership$361,658
P30 · FY2011 · CA · contact PI
Integrated Genomics Profile of Relapsed Childhood Acute Lymphoblastic Leukemia$178,275
R21 · FY2011 · CA · contact PI
Planning and Evaluation$54,514
P30 · FY2011 · CA · contact PI
Cancer Center Support Grant$2,644,237
P30 · FY2010 · CA · contact PI
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)$605,310
R01 · FY2010 · CA · contact PI
Sr. Leadership$380,693
P30 · FY2010 · CA · contact PI
Integrated Genomics Profile of Relapsed Childhood Acute Lymphoblastic Leukemia$220,545
R21 · FY2010 · CA · contact PI
Planning and Evaluation$57,384
P30 · FY2010 · CA · contact PI
Cancer Center Support Grant$2,644,237
P30 · FY2009 · CA · contact PI
Development$403,724
P30 · FY2009 · CA · contact PI
Sr. Leadership$395,047
P30 · FY2009 · CA · contact PI
Administration$155,452
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$99,705
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$93,456
P30 · FY2009 · CA · contact PI
Planning and Evaluation$59,547
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$2,640,338
P30 · FY2008 · CA · contact PI
Development$229,531
P30 · FY2008 · CA · contact PI
Sr. Leadership$224,597
P30 · FY2008 · CA · contact PI
Administration$88,380
P30 · FY2008 · CA · contact PI
Planning and Evaluation$33,855
P30 · FY2008 · CA · contact PI
Cancer Center Support Grant$2,563,433
P30 · FY2007 · CA · contact PI
POST TRANSCRIPTIONAL CONTROL OF THE HUMAN N MYC GENE$305,100
R01 · FY2002 · CA
POST TRANSCRIPTIONAL CONTROL OF THE HUMAN N MYC GENE$269,700
R01 · FY2001 · CA
CHILDRENS CANCER GROUP$122,770
U10 · FY2001 · CA
POST TRANSCRIPTIONAL CONTROL OF THE HUMAN N MYC GENE$269,100
R01 · FY2000 · CA
CHILDRENS CANCER GROUP$119,063
U10 · FY2000 · CA
CELL DIFFERENTIATION AND ONTOGENY OF HEMATOPOIESIS$78,600
P50 · FY2000 · DK